23 okt: Få VIP-billet til Invest 2007 - kvit og frit
24 okt: Fabricius og Kastholms møbelklassikere
24-10-2006 11:39:00

Hugin Ad hoc announcement according to § 15 WpHG: Misc. business figure: STRATEC Biomedical Systems AG: STRATEC clearly exceeds earnings for overall previous year after only nine months

Birkenfeld, October 24, 2006

The Board of Management of STRATEC Biomedical Systems AG, which is

listed in the Prime Standard and Gate-M indices, hereby announces the

preliminary, unaudited consolidated figures based on IFRS

(International Financial Reporting Standards) of the STRATEC Group

for the first nine months of the 2006 financial year pursuant to

Section 15 of the German Securities Trading Act (WpHG).

+-------------------------------------------------------------------+

| Key Figures (EUR | 01.01.- | 01.01.- | Change |

| 000s) | 09.30.2006 | 09.30.2005 | |

|---------------------+-----------------+-----------------+---------|

| Sales | 51,933 | 33,945 | + 53.0% |

|---------------------+-----------------+-----------------+---------|

| Gross performance | 51,887 | 35,582 | + 45.8% |

|---------------------+-----------------+-----------------+---------|

| EBITDA | 8,295 | 5,315 | + 56.1% |

|---------------------+-----------------+-----------------+---------|

| EBIT | 7,199 | 4,587 | + 56.9% |

|---------------------+-----------------+-----------------+---------|

| EBT | 7,097 | 4,409 | + 61.0% |

|---------------------+-----------------+-----------------+---------|

| Consolidated net | 5,304 | 2,895 | + 83.2% |

| income | | | |

|---------------------+-----------------+-----------------+---------|

| Earnings per share | 0.48 | 0.29 | + 65.5% |

| (EUR) | | | |

+-------------------------------------------------------------------+

The STRATEC Group had a total of 215 employees as of

September 30, 2006 (previous year: 189).

Information and disclosures concerning this ad-hoc announcement:

Irrespective of possible new levels of sales and earnings correlating

with the market launch of new analyzer system families, the company

assumes that the seasonal fluctuations witnessed in sales and

earnings in the past will be increasingly countered by logistical

measures involving procurement and production.

In the past 2005 financial year, the STRATEC Group had an average of

191 employees and generated sales of Euro 47.3 million, earnings

before tax (EBT) of Euro 6.9 million and consolidated income of Euro

4.4 million, with earnings per share of Euro 0.43 (earnings for

overall previous year).

The extensive interim report will be available on our internet page

as a download from around 3 p.m. on November 8, 2006.

Based on current budgeting, the growth forecast for the company will

be reflected in particular from the second and third quarter of the

2007 financial year onwards.

About STRATEC

STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de)

designs and manufactures fully automated systems for its partners in

the fields of clinical diagnostics and biotechnology. These partners

market such systems, in general together with their own reagents, to

laboratories and research institutes around the world. The company

develops its products on the basis of its own patented technologies.

Shares in the company (SIN: 728900 / ISIN: DE0007289001) are traded

in the Prime Standard segment of the Frankfurt Stock Exchange, in the

Gate-M trading segment of the Stuttgart Stock Exchange and on other

exchanges.

The STRATEC Group comprises the listed holding company "STRATEC

Biomedical Systems AG", as well as the subsidiaries "STRATEC NewGen",

"Robion" and "Sanguin".

Further information can be obtained from:

STRATEC Biomedical Systems AG

André Loy, Investor Relations

Gewerbestrasse 37, 75217 Birkenfeld

Germany

Tel: +49 7082 7916-190

Fax: +49 7082 7916-999

E-Mail: ir@stratec-biomedical.de

--- End of Ad-hoc Message ---

WKN: 728900; ISIN: DE0007289001;

Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Gate-M in

Börse Stuttgart,

Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse

München,

Freiverkehr in Börse Düsseldorf;

Copyright © Hugin ASA . All rights reserved.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
31 jul
TORM-A
Mit syn på Torm, og hvorfor jeg mener der er penge at hente som investor.    Der er 95,7 mia. Torm-a..
25
31 jul
ZEAL
Mange taler om LixiLan og hvor stort det kan blive - inklusiv mig selv!   Men Zealands lidt upræcise..
23
01 aug
ZEAL
Jeg skrev igår et indlæg om et projekt hos Zealand Pharma som indenfor meget overskuelig fremtid kan..
16
04 aug
BAVA
hermed mit bidrag.   Kerrigsdale snakker om at man skal huske at bruge Apple to apple metoden (side ..
15
31 jul
 
Kan vi ikke få en service meddelelse på hvad der sker med alle de korrreanske spam indlæg der flyder..
15
29 jul
OMXC20
Delfin har et indlæg om Varoufakis fra Lars Tvede som 10 personer har tomlet op. Læren er at Varoufa..
15
03 aug
TORM-A
  Et kig på prospektet i Torm       13.4.2.2 Prospective consolidated financial information for the ..
11
01 aug
EXQ
Jeg opdagede for et par uger siden at inrater.com havde lavet et system hvor man kunne oprette en mo..
11
29 jul
I:DAX
Alpe påstår ikke som dig at kunne forudsige markedet i detaljer, derimod giver han bud på sandsynlig..
11
03 aug
VWS
Energiwatch beskriver det ligefrem som at "Suzlon haler vinder ind på Vestas".   Hvad Børsen, Energi..
10

OPTAKT Novo Q2 6/8: Vækstprognosen kan stå foran et løft

04-08-2015 12:35:31
Der er udsigt til endnu et flot regnskab fra Novo Nordisk torsdag morgen.Salget af selskabets langtidsvirkende insulin Tresiba samt diabetesmedicinen Victoza fo..

Aktier/åbning: DSV belønnes og sørger for positivt C20

04-08-2015 09:16:10
Det danske aktiemarked er tirsdag åbnet i plus, og det er i høj grad takket være DSV, som i et stærkt regnskab tirsdag morgen opjusterede forventningerne. Efter..

Aktier/tendens: DSV ventes belønnet for stærkt regnskab

04-08-2015 08:26:10
Transport- og logistikkoncernen DSV vil være i fokus fra åbningen på det danske aktiemarked tirsdag, efter at selskabet har afleveret et stærkt regnskab, annonc..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
OPTAKT Novo Q2 6/8: Vækstprognosen kan stå foran et løft
2
Pandora/ABG: Løfter kursmålet til 1000 kr.
3
Aktier/tendens: DSV ventes belønnet for stærkt regnskab
4
Kina/Danske Invest: Hold snitterne fra Kina-aktier
5
DSV henter stærkt resultat og opjusterer

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
5. august 2015 01:57:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150804.2 - EUROWEB4 - 2015-08-05 01:57:57 - 2015-08-05 01:57:57 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x